Akari Therapeutics PLC (AKTX) — Cash Flow Reinvestment Rate
Latest as of March 2019:
0.00x
Akari Therapeutics PLC (AKTX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $228.94K. See Akari Therapeutics PLC balance sheet quality to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$228.94K
USD
Capital Expenditures
$0.00
USD
Annual Cash Flow Reinvestment Rate for Akari Therapeutics PLC (None–None)
Year-by-year capital reinvestment analysis for Akari Therapeutics PLC. For live market cap and broader valuation context, see Akari Therapeutics PLC (AKTX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow